Research progress on the relationship between Müller cell-mediated IL-17 signaling pathway and diabetic retinopathy
Journal Title: Eye Science (Yanke Xuebao) - Year 2024, Vol 39, Issue 10
Abstract
Diabetes retinopathy (DR) is a common ocular complication of diabetes, characterized by a complex pathological process involving multiple cells and inflammatory factors. Müller cells, as the primary supporting cells of the retina, not only produce interleukin-17 (IL-17) but also serve as a primary target in DR. They participate in the pathological process of DR by contributing to abnormal glutamate metabolism, increased secretion of vascular endothelial growth factor (VEGF), and regulatory functions, thereby exacerbating the inflammatory response. IL-17 is primarily secreted by T helper cell 17 (Th17) cells and enhances the inflammatory response by promoting the secretion of various inflammatory mediators (such as cytokines, chemokines, and metalloproteinases), leading to retinal microvascular damage and neuronal apoptosis, which accelerates the progression of DR. In a high-glucose environment, Müller cell function is impaired, and IL-17 further exacerbates this dysfunction, creating a vicious cycle. Studies have shown that blocking the IL-17 and Act1/TRAF6/NF-κB signaling pathways can mitigate the pathological changes associated with DR, providing new insights for the treatment of this disease. Therefore, conducting in-depth research on the interaction mechanism between IL-17 and Müller cells in DR is of great significance for exploring the pathogenesis of this disease and developing precise and effective treatment strategies.
Authors and Affiliations
Shanshan HUANG, Fang DUAN
Keywords
Related Articles
- EP ID EP761484
- DOI 10.12419/24070105
- Views 21
- Downloads 0
Research progress on the pathogenesis of primary acquired nasolacrimal duct obstruction
Primary acquired nasolacrimal duct obstruction (PANDO), which mainly occurs in the middle-aged and elderly women, is the most common type of obstructive diseases of the lacrimal duct, and it is also a common and frequent...
Research progress in drug treatment of herpes simplex virus stromal keratitis
Herpes simplex virus stromal keratitis is one of the leading causes of corneal blindness. A topical corticosteroid agent in conjunction with an oral antiviral agent is the preferred treatment, which has the disadvantages...
Advances in the treatment of optic neuritis associated with neuromyelitis optica spectrum disorders
Optic neuritis associated with neuromyelitis optic spectrum disorders is a demyelinating inflammatory disease involving the optic nerve, often presents with severe vision loss, poor prognosis and high recurrence rate. Ti...
Current status on the change of glaucoma as the first irreversible blinding disease
Glaucoma not only is common, but also seriously damages the visual function of the patients, and is recognized as the first irreversible blinding disease in the world. After careful observation, we recognize that untimel...
Application of information management system based on Wechat platform in clinical genetic testing for ophthalmic genetic diseases
[Objective:] To optimize the follow-up approach for patients with ophthalmic genetic diseases through informational technology, reduce the loss rate of cases, and faciliate the efficient operation of the clinical laborat...